Zymeworks

$31.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.48 (+1.57%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Zymeworks and other stocks, options, and ETFs commission-free!

About ZYME

Zymeworks Inc., also called Zymeworks, is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes.

CEO

Ali Tehrani

Employees

355

Headquarters

Vancouver, British Columbia

Founded

2003

Market Cap

1.46B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

354.80K

High Today

$31.06

Low Today

$29.89

Open Price

$30.41

Volume

243.63K

52 Week High

$59.03

52 Week Low

$28.02

Analyst Ratings

80%

of 15 ratings

Buy

80%

Hold

20%

Sell

ZYME Earnings

-$1.43

-$0.95

-$0.48

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours